OTC Markets OTCPK - Delayed Quote USD

Novonesis A/S (NVZMF)

Compare
55.20 0.00 (0.00%)
At close: December 27 at 3:00:00 PM EST
Loading Chart for NVZMF
DELL
  • Previous Close 0.00
  • Open 56.30
  • Bid 55.20 x 40000
  • Ask 59.55 x 45900
  • Day's Range 56.30 - 56.30
  • 52 Week Range 49.89 - 71.52
  • Volume 100
  • Avg. Volume 653
  • Market Cap (intraday) 26.488B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 56.91
  • EPS (TTM) 0.97
  • Earnings Date Feb 26, 2025
  • Forward Dividend & Yield 1.18 (2.14%)
  • Ex-Dividend Date Aug 29, 2024
  • 1y Target Est --

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

www.novonesis.com

10,452

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NVZMF

View More

Performance Overview: NVZMF

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NVZMF
1.34%
OMX Copenhagen 25 Index
4.44%

1-Year Return

NVZMF
7.85%
OMX Copenhagen 25 Index
0.00%

3-Year Return

NVZMF
26.19%
OMX Copenhagen 25 Index
9.83%

5-Year Return

NVZMF
23.36%
OMX Copenhagen 25 Index
0.00%

Compare To: NVZMF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NVZMF

View More

Valuation Measures

Annual
As of 12/27/2024
  • Market Cap

    26.60B

  • Enterprise Value

    28.40B

  • Trailing P/E

    57.00

  • Forward P/E

    26.32

  • PEG Ratio (5yr expected)

    0.23

  • Price/Sales (ttm)

    6.37

  • Price/Book (mrq)

    2.24

  • Enterprise Value/Revenue

    8.94

  • Enterprise Value/EBITDA

    57.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.29%

  • Return on Assets (ttm)

    3.45%

  • Return on Equity (ttm)

    4.38%

  • Revenue (ttm)

    3.04B

  • Net Income Avi to Common (ttm)

    282.79M

  • Diluted EPS (ttm)

    0.97

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    260.8M

  • Total Debt/Equity (mrq)

    18.08%

  • Levered Free Cash Flow (ttm)

    21.34M

Research Analysis: NVZMF

View More

Company Insights: NVZMF

Research Reports: NVZMF

View More

People Also Watch